Gene · 5266
Papers4,558
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,558
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRPML3/BK complex promotes autophagy and bacterial clearance by providing a positive feedback regulation of mTOR via PI3P. | Proc Natl Acad Sci U S A | 2023 | 37585464 | PubTator, text mining | PubMed |
The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase. | J Biomed Sci | 2023 | 37580757 | PubTator, text mining | PubMed |
| Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups. | Ann Rheum Dis | 2023 | 37580109 | PubTator, text mining | PubMed |
| TLR4 predicts patient prognosis and immunotherapy efficacy in clear cell renal cell carcinoma. | J Cancer | 2023 | 37576399 | PubTator, text mining | PubMed |
| Identification of Immuno-Inflammation-Related Biomarkers for Acute Myocardial Infarction Based on Bioinformatics. | J Inflamm Res | 2023 | 37576155 | PubTator, text mining | PubMed |
| Establishment of a prognostic model toward lung squamous cell carcinoma based on m7G-related genes in the cancer genome atlas. | Physiol Genomics | 2023 | 37575065 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target? | Int J Mol Sci | 2023 | 37569787 | PubTator, text mining | PubMed |
| Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models. | Int J Mol Sci | 2023 | 37569426 | PubTator, text mining | PubMed |
| Antioxidants Amelioration Is Insufficient to Prevent Acrylamide and Alpha-Solanine Synergistic Toxicity in BEAS-2B Cells. | Int J Mol Sci | 2023 | 37569330 | PubTator, text mining | PubMed |
| Elafin as a Prognostic Marker in Esophageal Squamous Cell Carcinoma: A Pilot Study Using Three-Dimensional Imaging and Genomic Profiling. | Cancers (Basel) | 2023 | 37568641 | PubTator, text mining | PubMed |
| Renal cancer secretome induces migration of mesenchymal stromal cells. | Stem Cell Res Ther | 2023 | 37563650 | PubTator, text mining | PubMed |
| Two new species of Sminthurididae (Hexapoda, Collembola, Symphypleona) from Brazil with notes on Denisiella Folsom & Mills and Sphaeridia Linnaniemi. | Zookeys | 2023 | 37560261 | PubTator, text mining | PubMed |
| DLBS3233 enhances nephrin and podocin expression also reduces oxidative stress marker and insulin receptor serine diabetic rats' podocytes. | Ann Med Surg (Lond) | 2023 | 37554909 | PubTator, text mining | PubMed |
| Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasis. | J Dermatol Sci | 2023 | 37543503 | PubTator, text mining | PubMed |
| A peek at the other side of the coin: Tumor-suppressor role of microRNAs expressed by pancreatic cancer-associated fibroblasts. | Clin Transl Med | 2023 | 37539872 | PubTator, text mining | PubMed |
| Biological markers of disease activity in inflammatory bowel diseases. | Prz Gastroenterol | 2023 | 37538284 | PubTator, text mining | PubMed |
| Transient power equalization control strategy of virtual synchronous generator in isolated island microgrid with heterogeneous power supply. | Sci Rep | 2023 | 37537262 | PubTator, text mining | PubMed |
| Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis. | Sci Rep | 2023 | 37532715 | PubTator, text mining | PubMed |
| A cost-effective and enhanced mesenchymal stem cell expansion platform with internal plasma-activated biofunctional interfaces. | Mater Today Bio | 2023 | 37529421 | PubTator, text mining | PubMed |
| Molecular classification of urothelial bladder carcinoma. | Mol Biol Rep | 2023 | 37525073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5266/papers?page=18